Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. James B. Breitmeyer, M.D.,PhD$26.1M
Market Cap • 15/04/20241997
(há 27 anos)
2004
(20 years ago)
NASDAQ
Listagem
San Diego
Sede • California30
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ONCTSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.